Millions of women with a breast cancer diagnosis could safely avoid debilitating chemotherapy that would not be effective, thanks to a tumour gene expression test. The OPTIMA trial, led by researchers ...

Prognostic and predictive impact of baseline gene expression (exp) in the NATALEE trial of adjuvant (adj) ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in HR+/HER2− early breast cancer ...

I have a drawer full of USB cables and every time I want to connect a device, I have to try them out. USB-C was supposed to simplify things: One cable for everything, that was the promise. In practice ...

You may know me from the Opinion pages of the print paper, where I have been an editor since 2017. Earlier this year I scrapped with Vice President JD Vance about free markets, which may have caught ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Across primary sites, histological subtypes, and mitotic count categories, clinicopathological factors and gene-expression profile results were consistent for discriminating SLN positivity rates.

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

[Colbert’s] political satire remained just as sharp, especially when Donald Trump came on the political scene that same year. Trump — who is not known to have a sense of humor, certainly not about ...

Forbes contributors publish independent expert analyses and insights. Kristen Bousquet is an influencer and creator monetization coach. Thousands of people every month search for ways to get paid to ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

Castle Biosciences (CSTL) provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis, or AD, who are seeking systemic treatment.